Skip to Content
Skip to Navigation
Home
Contact
Publications
Legal
Rehabilitation Evidence
>
Venous Thromboembolism
>
Prophylaxis of Venous Thromboembolism Post SCI
> Pharmacological Agents for DVT Prophylaxis
Pharmacological Agents for DVT Prophylaxis
Submitted by admin on Sat, 05/22/2010 - 23:03
‹ previous
next ›
Print this section
About SCIRE
Rehabilitation Evidence
Outcome Measures
Case Studies
Education Modules
SCI OM Toolkit
Rehabilitation Evidence
Aging
Autonomic Dysreflexia
Bladder Management
Bone Health
Bowel Management
Cardiovascular Health
Costs
Depression
Epidemiology
Heterotopic Ossification
Housing and Attendant Care
Lower Limb
Nutrition
Orthostatic Hypotension
Pain Management
Physical Activity
Pressure Ulcers
Primary Care
Rehabilitation Practices
Respiratory Management
Sexual Health
Spasticity
Syringomyelia
Upper Limb
Venous Thromboembolism
Wheelchairs and Seating Equipment
Work and Employment
Venous Thromboembolism
Incidence of Venous Thromboembolism Post SCI
Diagnosis of Venous Thromboembolism Post SCI
Prophylaxis of Venous Thromboembolism Post SCI
Pharmacological Agents for DVT Prophylaxis
Unfractionated Heparin as Prophylaxis for Venous Thromboembolism Post SCI
Low Molecular Weight Heparin (LMWH) as Prophylaxis Post SCI
LMWH vs. UFH as Prophylaxis for Venous Thromboembolism Post SCI
LMWH as a Prophylaxis of Venous Thrombosis
Prevention of DVT through Mechanical Methods
Vena Cava Filtration
Treatment of Acute Venous Thromboembolism in SCI
Summary
Key Points
References
Downloads
Download Venous Thromboembolism review
